2025. Complement Inhibition in Rare Kidney Disease: Response Heterogeneity and Biomarker-Guided Withdrawal. Translational Medicine & Therapeutics Journal. 4, 1 (Apr. 2025), 28–36. DOI:https://doi.org/10.5281/zenodo.22649336.